期刊文献+

成都市农村妇女两癌筛查现状及影响因素研究 被引量:3

Analysis of the results of two-cancer screening and related factors among rural women in Chengdu
原文传递
导出
摘要 目的:分析成都市35~64岁农村妇女乳腺癌和宫颈癌(简称两癌)筛查现状及影响因素,为农村适龄妇女两癌的防控提供参考。方法:对辖区内35~64岁的农村适龄妇女进行免费两癌筛查。乳腺癌筛查进行乳腺的视诊、触诊和彩超检查;宫颈癌筛查包括妇科检查、宫颈细胞学检查、阴道镜检查和组织病理学检查。对检查结果及影响因素进行统计分析。结果:本次筛查对象平均年龄(48.9±6.5)岁。乳腺超声BIRADS分级显示,3级占7.1%,4级占1.4%。宫颈细胞学异常率为8.9%,阴道镜检查异常率为22.0%,病理活检宫颈癌检出率为76.6/10万,癌前病变检出率为919.0/10万。多因素Logistic回归分析显示:年龄(OR=0.895,95%CI 0.842~0.953)是乳腺BI-RADS分级评分高级别的保护因素(P<0.05),既往做过乳腺手术或活检(OR=2.884,95%CI 1.305~6.375)、乳房结节(OR=2.536,95%CI 1.638~3.926)、乳房团块(OR=8.383,95%CI 1.929~36.435)、乳房肿块(OR=8.092,95%CI 2.116~30.945)是乳腺BI-RADS分级评分高级别的危险因素(均P<0.05),绝经(OR=0.697,95%CI 0.529~0.918)、避孕套避孕(OR=0.625,95%CI 0.434~0.900)是宫颈细胞学检查异常的保护因素(均P<0.05)。结论:农村妇女免费两癌筛查中,应将35~49岁年龄段,既往做过乳腺手术或活检,乳腺体检中发现乳房结节、乳房团块、乳房肿块,未绝经妇女、未使用避孕套避孕等妇女,作为重点关注对象,达到早发现、早诊断、早治疗的目的,改善农村妇女健康水平。 Objective:To provide evidence for prevention and control of cervical cancer and breast cancer(short for the two-cancers)in rural women aged at 35 to 64 years via investigating their current status of screening and influencing factors.Methods:Free screening for the two-cancers were conducted for the rural women aged at 35 to 64 years old in the district.The breast cancer screening involves visual inspection,palpation,and ultrasound color doppler of the breast.Cervical cancer screening includes gynecological examination,cervical cytology,colposcopy,and histopathology examinations.Statistical analyses were performed to analyze the influencing factors of the results of those screening tests.Results:The average age of the screened women was(48.9±6.5)years old.As for the breast cancer,women with BI-RADS grade-3 and grade-4 measured via breast ultrasonography consisted of 7.1%and 1.4%of all participants,respectively.As for the screening results of the cervical cancer,8.9%participants had abnormal cervical cytology,and 22%of women who underwent colposcopy test had abnormal results.The detection rate of cervical cancer and precancerous lesions using pathological biopsy was 76.6/100000,and 919.0/100000,respectively.Results from the multivariate Logistic regression analyses showed that age(OR=0.895,95%CI 0.842-0.953)was a protective factor for BI-RADS grading score(P<0.05),and having undergone breast surgery or biopsy(OR=2.884,95%CI 1.305-6.375),having breast nodules(OR=2.536,95%CI 1.638-3.926),having breast lumps(OR=8.383,95%CI 1.929-36.435),and having breast mass(OR=8.092,95%CI 2.116-30.945)are risk factors for higher-grade BI-RADS score(P<0.05).Menopause(OR=0.697,95%CI 0.529-0.918)and condom contraception(OR=0.625,95%CI 0.434-0.900)were protective factors for abnormal cervical cytology(P<0.05).Conclusion:Women who were 35-49 years old,have undergone breast surgery or biopsy,had breast nodules,breast lumps,or breast lumps,were premenopausal,or had not used condoms for contraception should be focused on in the two-cancers screening in rural women.This will help with early detection,early diagnosis,and early treatment of the two-cancers,and improve the health level of rural women.
作者 魏玉兰 王欢欢 王娟秀 冯斐 沈丽琴 WEI Yulan;WANG Huanhuan;WANG Juanxiu;FENG Fei;SHEN Liqin(Department of Gynecology and Obstetrics,Chengdu Wenjiang District Maternal and Child Health Hospital,Chengdu 611130,China;Department of health Care,Chengdu Wenjiang District Maternal and Child Health Hospital,Chengdu 611130,China;Department of Maternal,Child and Adolescent Health,West China School of Public Health,Sichuan 610041,China)
出处 《现代医学》 2022年第10期1274-1282,共9页 Modern Medical Journal
关键词 农村 妇女 两癌筛查 影响因素 rural area women screening for the two-cancers related factors
  • 相关文献

参考文献15

二级参考文献148

  • 1徐慧芳,余艳琴,邵晨轶,张询,胡尚英,赵方辉,乔友林.DH3与cobas4800在宫颈癌筛查中的效果对比研究[J].中国肿瘤临床与康复,2020,0(2):129-132. 被引量:6
  • 2赵娜,赵方辉,高晓虹,等.城市和农村妇女高危型人乳头瘤病毒感染的危险因素分析[J].中华肿瘤防治杂志,2011,18(16):1225-1229.
  • 3马立岩.采用钼钯对妇女乳腺普查及定期检查的价值[J].中国保健,2007,15(7):61-62. 被引量:5
  • 4郎景和.子宫颈癌预防的现代策略[J].中国医学科学院学报,2007,29(5):575-578. 被引量:222
  • 5WHO. WHO guidelines for screening and treatment of precancerous lesions for cervical cancer prevention. World Health Organization, 2013 [EB/OL]. [2015-09-01]. http . /Iwww.who.inlJreproductivehealthlpublicationslcancers! screening_and_treatment_of_precancerous_lesions/en/.
  • 6Cox JT. Human papillomavirus testing in primary cervical screening and abnormal papanicolaou management. Obstet GynecolSurv, 2006, 61: S15-25.
  • 7Wang R, Guo X, Wisman GBA, et al.Nationwide prevalence of human papillomavirus infection and viral genotype distribution in 37 cities in China. BMC Infect Dis, 2015, 15. 257-267.
  • 8de Sanjose S, Diaz M, Castellsague X, et al.Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta- analysis. Lancet Infect Dis, 2007, 7: 453-459.
  • 9Wright TC Jr, Stoler MH, Sharma A, et al. Evaluation of HPV-16 and HPV-18 genotyping for the triage of women with high-risk HPV+cytology-negative results. Am J Clin Pathol, 2011, 136: 578-586.
  • 10Ciapponi A, Bardach A, Glujovsky D, et al. The type-specific HPV prevalence in cervical cancer and high-grade lesions in Latin America and the Caribbean: systematic review and meta- analysis.PLoSOne, 2011, 6: e25493.

共引文献288

同被引文献36

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部